Infliximab for acute exacerbations of ulcerative colitis

NICE technology appraisals [TA163] Published date:

Infliximab is recommended as a possible treatment for people with acute, severely active ulcerative colitis only if:

  • ciclosporin is considered inappropriate for them, or
  • they are taking part in a research study (clinical trial)

Get involved